Eric Madore
Laval University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eric Madore.
Journal of Biological Chemistry | 2003
Eric Madore; Nathalie Harvey; Julie Parent; Pierre Chapdelaine; J. A. Arosh; Michel A. Fortier
Prostaglandins are important regulators of reproductive function. In particular, prostaglandin F2α (PGF2α) is involved in labor and is the functional mediator of luteolysis to initiate a new estrous cycle in many species. These actions have been extensively studied in ruminants, but the enzymes involved are not clearly identified. Our objective was to identify which prostaglandin F synthase is involved and to study its regulation in the endometrium and in endometrial primary cell cultures. The expression of all previously known prostaglandin F synthases (PGFSs), two newly discovered PGFS-like genes, and a 20α-hydroxysteroid dehydrogenase was studied by Northern blot and reverse transcription PCR. These analyses revealed that none of the known PGFS or the PGFS-like genes were significantly expressed in the endometrium. On the other hand, the 20α-hydroxysteroid dehydrogenase gene was strongly expressed in the endometrium at the time of luteolysis. The corresponding recombinant enzyme has aK m of 7 μm for PGH2 and a PGFS activity higher than the lung PGFS. This enzyme has two different activities with the ability to terminate the estrous cycle; it metabolizes progesterone and synthesizes PGF2α. Taken together, these data point to this newly identified enzyme as the functional endometrial PGFS.
Biology of Reproduction | 2003
Gilles Frenette; Carl Lessard; Eric Madore; Michel A. Fortier; Robert Sullivan
Abstract During the epididymal transit, mammalian spermatozoa acquire new surface proteins necessary for male gamete function. We have previously shown that membranous vesicles, called epididymosomes, interact with spermatozoa allowing the transfer of some proteins to sperm surface within the epididymal lumen. The protein composition of those vesicles has been investigated to document the mechanisms of protein transfer from epididymosomes to spermatozoa. Electrophoretic analysis revealed that protein composition is different from the epididymal soluble compartment as well as from similar vesicles present in the semen. Protein association with epididymosome is very strong as revealed by resistance to extraction with detergent. Matrix-assisted laser desorption ionization time-of-flight as well as immunodetection techniques have been used to identify some proteins associated to epididymosomes and spermatozoa. An aldose reductase known for its 20α-hydroxysteroid dehydrogenase activity and the cytokine (macrophage migration inhibitory factor) have been identified. These two proteins have been immunolocalized in principal cells of the epididymal epithelium, a more intense signal being detected in the distal epididymal segment as well as in the vas deferens. Database search revealed that these two proteins are characterized by the lack of a signal peptide. These results are discussed with regard to a possible apocrine mode of secretion of these proteins acquired by spermatozoa during the epididymal transit.
The Journal of Clinical Endocrinology and Metabolism | 2011
Eva Bresson; Sofia Boucher-Kovalik; Pierre Chapdelaine; Eric Madore; Nathalie Harvey; Philippe Y. Laberge; Mathieu Leboeuf; Michel A. Fortier
CONTEXT Prostaglandins (PGs) E2 and PGF2α are produced in the endometrium and are important for menstruation and fertility. Dysmenorrhea is associated with increased production of PGF2α relative to PGE2, and the opposite is true for menorrhagia. The pathways leading to PGE2 biosynthesis are well described, but little is known for PGF2α. Aldoketoreductase (AKR)-1C3, the only PGF synthase identified in the human, cannot explain the production of PGF2α by endometrial cells. AKR1B1 appears to be an alternate candidate with promising therapeutic value. OBJECTIVE The objective of the study was to address whether AKR1B1 (gene ID 231) is a functional PGF2α synthase in the human endometrium and a valid therapeutic target for menstrual pain. DESIGN The design of the study was basic laboratory analyses to identify gene expression and protein levels associated with PGF2α production in endometrial tissues and endometrial cells from cycling women aged between 23 and 52 yr undergoing biopsies or hysterectomy for diverse gynecological disorders. RESULTS AKR1B1 is expressed at a high level during the menstrual cycle during the secretory phase and in both epithelial and stromal cells, whereas AKR1C3 was found only in epithelial cells. Purified recombinant AKR1B1 protein, gene silencing, and transient transfection experiments all concur to demonstrate that this enzyme is a functional PGF synthase. Ponalrestat, a specific inhibitor developed to block AKR1B1 activity, reduced PGF2α production in response to IL-1β in both cultured endometrial cells and endometrial explants. CONCLUSIONS The human aldose reductase AKR1B1 currently associated with diabetes complications is also a highly functional PGF synthase responsible for PGF2α production in the human endometrium and a potential target for treatment of menstrual disorders.
Biochemical Journal | 2010
Xiaoli Shi; Sandrine Opi; Adrien Lugari; Audrey Restouin; Thibault Coursindel; Isabelle Parrot; Javier Pérez; Eric Madore; Pascale Zimmermann; Jacques Corbeil; Mingdong Huang; Stefan T. Arold; Yves Collette; Xavier Morelli
SFKs (Src family kinases) are central regulators of many signalling pathways. Their functions are tightly regulated through SH (Src homology) domain-mediated protein-protein interactions. A yeast two-hybrid screen using SH3 domains as bait identified Alix [ALG-2 (apoptosis-linked gene 2)-interacting protein X] as a novel Hck (haemopoietic cell kinase) SH3 domain interactor. The Alix-Hck-SH3 interaction was confirmed in vitro by a GST (glutathione transferase) pull-down assay and in intact cells by a mammalian two-hybrid assay. Furthermore, the interaction was demonstrated to be biologically relevant in cells. Through biophysical experiments, we then identified the PRR (proline-rich region) motif of Alix that binds Hck-SH3 and determined a dissociation constant of 34.5 μM. Heteronuclear NMR spectroscopy experiments were used to map the Hck-SH3 residues that interact with an ALIX construct containing the V and PRR domains or with the minimum identified interacting motif. Finally, SAXS (small-angle X-ray scattering) analysis showed that the N-terminal PRR of Alix is unfolded, at least before Hck-SH3 recognition. These results indicate that residues outside the canonical PxxP motif of Alix enhance its affinity and selectivity towards Hck-SH3. The structural framework of the Hck-Alix interaction will help to clarify how Hck and Alix assist during virus budding and cell-surface receptor regulation.
Endocrinology | 2004
J. A. Arosh; S. K. Banu; Pierre Chapdelaine; Eric Madore; Jean Sirois; Michel A. Fortier
Proteomics | 2006
François McNicoll; Jolyne Drummelsmith; Michaela Müller; Eric Madore; Nathalie Boilard; Marc Ouellette; Barbara Papadopoulou
FEBS Journal | 1999
Eric Madore; Catherine Florentz; Richard Giegé; Shun-ichi Sekine; Shigeyuki Yokoyama; Jacques Lapointe
The Journal of Clinical Endocrinology and Metabolism | 2005
Jihong Kang; Pierre Chapdelaine; Julie Parent; Eric Madore; Philippe Y. Laberge; Michel A. Fortier
Nucleic Acids Research | 1999
Eric Madore; Catherine Florentz; Richard Giegé; Jacques Lapointe
Reproduction | 2006
Marianne Parent; Eric Madore; Leslie A. MacLaren; Michel A. Fortier